Agfa sees increased sales in 1998
Bayer’s Agfa division reported its fiscal 1998 results last month. Agfa saw sales rise by 5% to DM 8.5 billion ($4.7 billion), as compared with DM 8.1 billion ($4.5 billion) in 1997. Its operating profit declined by 12.9% to $2.7 million, which the
Bayers Agfa division reported its fiscal 1998 results last month. Agfa saw sales rise by 5% to DM 8.5 billion ($4.7 billion), as compared with DM 8.1 billion ($4.5 billion) in 1997. Its operating profit declined by 12.9% to $2.7 million, which the company attributed to the Asian financial crisis.
Sales in Agfas technical imaging systems division climbed 8% in 1998 as compared with 1997, from $993 million to $1 billion. The groups medical business unit contributed about three-quarters of the divisions sales, Bayer said. In January, Agfa moved to acquire Sterling Diagnostic Imaging (SCAN 1/20/99), and the purchase should be completed this spring, according to the company.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
